Free Republic
Browse · Search
General/Chat
Topics · Post Article

The levels of each test considered “higher” were those in the top 20% of results.
1 posted on 11/06/2025 3:27:06 PM PST by ConservativeMind
[ Post Reply | Private Reply | View Replies ]


To: Mazey; ckilmer; goodnesswins; Jane Long; jy8z; ProtectOurFreedom; matthew fuller; telescope115; ...

The “Take Charge Of Your Health” Ping List

This high volume ping list is for health articles and studies which describe something you or your doctor, when informed, may be able to immediately implement for your benefit.

Email me to get on either the “Common/Top Issues” (20 - 25% fewer pings) or “Everything” list.

2 posted on 11/06/2025 3:27:38 PM PST by ConservativeMind (Trump: Befuddling Democrats, Republicans, and the Media for the benefit of the US and all mankind.)
[ Post Reply | Private Reply | To 1 | View Replies ]

To: ConservativeMind

I will see if I can get these. Thanks for the info.


3 posted on 11/06/2025 3:35:14 PM PST by KittyKares
[ Post Reply | Private Reply | To 1 | View Replies ]

To: ConservativeMind

Lp(a) is all the rage, presumably because there’s now a test for it, but its levels are determined by genetics, not lifestyle, and there are no medications currently approved specifically to lower Lp(a) [so what’s the point of testing for something that can’t be fixed?]:

question to Grok: “Are there any medications currently available whose purpose is specifically to lower Lipoprotein(a)?”

Grok: “No, there are currently no medications specifically approved by the FDA or other major regulatory agencies whose primary purpose is to lower Lipoprotein(a) (Lp(a)) levels.

Lp(a) is a genetically determined risk factor for cardiovascular disease, and while some existing treatments can modestly reduce it as a secondary effect, none are indicated or designed explicitly for this goal.

Key Points:

Existing Options with Secondary Lp(a) Effects:PCSK9 inhibitors (e.g., alirocumab/Praluent, evolocumab/Repatha):

These primarily target LDL cholesterol but can lower Lp(a) by 20–30%. They are approved only for high LDL-C or cardiovascular risk reduction, not Lp(a).”


4 posted on 11/06/2025 4:01:09 PM PST by catnipman ((A Vote For The Lesser Of Two Evils Still Counts As A Vote For Evil))
[ Post Reply | Private Reply | To 1 | View Replies ]

To: dadgum

PING CVD and lipid markers


5 posted on 11/06/2025 4:02:46 PM PST by dadgum (Fight to WIN or do not fight at all !!!)
[ Post Reply | Private Reply | To 1 | View Replies ]

Free Republic
Browse · Search
General/Chat
Topics · Post Article


FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson